利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

11 条记录 (耗时 0.021 秒)

    Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation
    2.
    发明授权
    Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation 失效
    取代（芳基烷氧基苄基）氨基丙酰胺衍生物及其制备方法

    公开(公告)号：US5446066A

    公开(公告)日：1995-08-29

    申请号：US215628

    申请日：1994-03-22

    申请人： Mario Varasi ,  Philippe Dostert ,  Paolo Pevarello ,  Alberto Bonsignori

    发明人： Mario Varasi ,  Philippe Dostert ,  Paolo Pevarello ,  Alberto Bonsignori

    IPC分类号： A61K31/165 ,  A61P25/00 ,  A61P25/08 ,  A61P25/20 ,  A61P25/24 ,  A61P25/26 ,  C07C231/10 ,  C07C237/00 ,  C07C237/06 ,  C07C233/04

    CPC分类号： C07C237/00

    摘要： The invention provides new compounds of formula (I) ##STR1## wherein, subject to a proviso, n is zero or an integer of 1 to 3; each of R and R.sub.1, which may be the same or different, is hydrogen, halogen, trifluoromethyl or C.sub.1 -C.sub.4 alkoxy; R.sub.2 is hydrogen or C.sub.1 -C.sub.4 alkyl optionally substituted by hydroxy; each of R.sub.3 and R.sub.4 independently is hydrogen or C.sub.1 -C.sub.4 alkyl; or a pharmaceutically acceptable salt thereof; and of formula (IA) ##STR2## wherein R.sub.5 is hydrogen, halogen, trifluoromethyl or C.sub.1 -C.sub.4 alkoxy, or a pharmaceutically acceptable salt thereof, which are active on the central nervous system (CNS) and can be used in therapy as anti-epileptics, anti-Parkinson, neuroprotective, antidepressant, anti-spastic and hypnotic agents.

    摘要翻译： 本发明提供新的式（I）化合物其中，条件是n为0或1〜3的整数; R和R 1可以相同或不同，为氢，卤素，三氟甲基或C 1 -C 4烷氧基; R2是氢或任选被羟基取代的C 1 -C 4烷基; R 3和R 4各自独立地是氢或C 1 -C 4烷基; 或其药学上可接受的盐; 和式（IA）的化合物（IA）其中R5是氢，卤素，三氟甲基或C1-C4烷氧基，或其药学上可接受的盐，其在中枢神经系统（CNS）上是有活性的并且可以用于治疗 作为抗癫痫药，抗帕金森综合征，神经保护药，抗抑郁药，抗痉挛药和催眠药。

    Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
    5.
    发明授权
    Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation 失效
    取代的（芳基烷基氨基苄基）氨基丙酰胺衍生物及其制备方法

    公开(公告)号：US5449692A

    公开(公告)日：1995-09-12

    申请号：US215694

    申请日：1994-03-22

    申请人： Mario Varasi ,  Philippe Dostert ,  Paolo Pevarello ,  Alberto Bonsignori

    发明人： Mario Varasi ,  Philippe Dostert ,  Paolo Pevarello ,  Alberto Bonsignori

    IPC分类号： A61K31/165 ,  A61P25/00 ,  A61P25/08 ,  A61P25/20 ,  A61P25/24 ,  A61P25/26 ,  A61P43/00 ,  C07C231/10 ,  C07C237/06 ,  C07C233/05

    CPC分类号： C07C237/06

    摘要： The invention provides new compounds of formula (I) ##STR1## wherein n is an integer of 1 to 4; each of R and R.sub.1, which may be the same or different, is hydrogen, halogen, trifluoromethyl or C.sub.1 -C.sub.4 alkoxy; R2 is hydrogen or C.sub.1 -C.sub.4 alkyl; and a pharmaceutically acceptable salts thereof; and wherein when, at the same time, R is hydrogen, R.sub.1 is hydrogen or halogen and n is one, then R.sub.2 is other than hydrogen or methyl; and of formula (IA) ##STR2## wherein R.sub.3 is halogen, and a pharmaceutical acceptable salt thereof, which are active on the central nervous system (CNS) and can be used in therapy as anti-epileptics, anti-Parkinson, neuroprotective, antidepressant, anti-spastic and hypnotic agents.

    摘要翻译： 本发明提供新的式（I）化合物其中n为1至4的整数; R和R 1可以相同或不同，为氢，卤素，三氟甲基或C 1 -C 4烷氧基; R2是氢或C1-C4烷基; 及其药学上可接受的盐; 并且其中当R同时为氢时，R 1为氢或卤素且n为1，则R 2为氢或甲基; 和式（IA）其中R 3是卤素的式（IA）及其药学上可接受的盐，其在中枢神经系统（CNS）上是有活性的，可用于治疗作为抗癫痫药，抗帕金森病， 神经保护，抗抑郁药，抗痉挛药和催眠药。

    Piperazine-substituted 1,4-benzoxazine derivatives and their use in treating disorders of the central nervous system
    7.
    发明授权
    Piperazine-substituted 1,4-benzoxazine derivatives and their use in treating disorders of the central nervous system 失效
    哌嗪取代的1,4-苯并恶嗪衍生物及其在治疗中枢神经系统疾病中的应用

    公开(公告)号：US5229383A

    公开(公告)日：1993-07-20

    申请号：US748221

    申请日：1991-08-20

    申请人： Mario Varasi ,  Piero Melloni ,  Maria A. Cervini ,  Alberto Bonsignori ,  Roberto Commisso

    发明人： Mario Varasi ,  Piero Melloni ,  Maria A. Cervini ,  Alberto Bonsignori ,  Roberto Commisso

    IPC分类号： C07D265/36 ,  C07D279/16 ,  C07D471/10

    CPC分类号： C07D471/10 ,  C07D265/36 ,  C07D279/16

    摘要： The present invention relates to compounds having the following formula (I) ##STR1## wherein X represents --O-- or --S--;each of R and R.sub.1, independently, is hydrogen, halogen, hydroxy, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, amino, nitro or trihalo-C.sub.1 -C.sub.6 alkyl;each of R.sub.2 and R.sub.3, independently, is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, C.sub.2 -C.sub.6 alkynyl or phenyl-C.sub.1 -C.sub.6 alkyl; or R.sub.2 and R.sub.3, taken together with the nitrogen atom to which they are linked, form an unsubstituted or substituted, 6-membered, saturated, heteromonocyclic ring optionally containing a further heteroatom chosen from oxygen, sulphur and nitrogen;each of R.sub.4 and R.sub.5, independently, is hydrogen, halogen, nitro, amino or trihalo-C.sub.1 -C.sub.6 alkyl; and the pharmaceutically acceptable salts thereof.The compounds of the invention are useful in therapy as major tranquilizers e.g., in the management of psychotic disorders.

    摘要翻译： 本发明涉及具有下式（I）的化合物：其中X表示-O-或-S-; R和R 1各自独立地是氢，卤素，羟基，C 1 -C 6烷基，C 1 -C 6烷氧基，氨基，硝基或三卤代-C 1 -C 6烷基; R 2和R 3各自独立地是氢，C 1 -C 6烷基，C 2 -C 6烯基，C 2 -C 6炔基或苯基-C 1 -C 6烷基; 或R 2和R 3与它们所连接的氮原子一起形成任选含有另外选自氧，硫和氮的杂原子的未取代或取代的6元饱和的杂单环; R 4和R 5各自独立地是氢，卤素，硝基，氨基或三卤代-C 1 -C 6烷基; 及其药学上可接受的盐。 本发明的化合物可用于作为主要镇静剂的治疗，例如在精神病性障碍的治疗中。

    2-(piperidinylmethyl)-4-phenyl-2,3-dihydro-4H-1,4-benzoxazines useful as antipsychotics
    8.
    发明授权
    2-(piperidinylmethyl)-4-phenyl-2,3-dihydro-4H-1,4-benzoxazines useful as antipsychotics 失效
    2-（哌啶基甲基）-4-苯基-2,3-二氢-4H-1,4-苯并恶唑作为抗生素有用

    公开(公告)号：US5084454A

    公开(公告)日：1992-01-28

    申请号：US434689

    申请日：1989-10-11

    申请人： Mario Varasi ,  Piero Melloni ,  Maria A. Cervini ,  Alberto Bonsignori ,  Roberto Commisso

    发明人： Mario Varasi ,  Piero Melloni ,  Maria A. Cervini ,  Alberto Bonsignori ,  Roberto Commisso

    IPC分类号： A61K31/535 ,  A61K31/538 ,  A61K31/54 ,  A61K31/5415 ,  A61P25/00 ,  A61P25/18 ,  A61P25/24 ,  C07D265/36 ,  C07D279/16 ,  C07D413/04 ,  C07D417/04 ,  C07D471/10

    CPC分类号： C07D471/10 ,  C07D265/36 ,  C07D279/16

    摘要： The present invention relates to compounds having the following formula (I) ##STR1## wherein X represents --O-- or --S--;each of R and R.sub.1, independently, is hydrogen, halogen, hydroxy, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, amino, nitro or trihalo-C.sub.1 -C.sub.6 alkyl;each of R.sub.2 and R.sub.3, independently, is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, C.sub.2 -C.sub.6 alkynyl or phenyl-C.sub.1 -C.sub.6 alkyl; or R.sub.2 and R.sub.3, taken together with the nitrogen atom to which they are linked, form an unsubstituted or substituted, 6-membered, saturated, heteromonocyclic ring optionally containing a further heteroatom chosen from oxygen, sulphur and nitrogen;each of R.sub.4 and R.sub.5, independently, is hydrogen, halogen, nitro, amino or trihalo-C.sub.1 -C.sub.6 alkyl; and the pharmaceutically acceptable salts thereof. The compounds of the invention are useful in therapy as major tranquilizers e.g., in the management of psychotic disorders.

    摘要翻译： PCT No.PCT / EP89 / 00130 Sec。 371日期：1989年10月11日 102（e）日期1989年10月11日PCT提交1989年2月13日PCT公布。 出版物WO89 / 07596 日本1989年8月24日。本发明涉及具有下式（I）的化合物：其中X表示-O-或-S-; R和R 1各自独立地是氢，卤素，羟基，C 1 -C 6烷基，C 1 -C 6烷氧基，氨基，硝基或三卤代-C 1 -C 6烷基; R 2和R 3各自独立地是氢，C 1 -C 6烷基，C 2 -C 6烯基，C 2 -C 6炔基或苯基-C 1 -C 6烷基; 或R 2和R 3与它们所连接的氮原子一起形成任选含有另外选自氧，硫和氮的杂原子的未取代或取代的6元饱和的杂单环; R 4和R 5各自独立地是氢，卤素，硝基，氨基或三卤代-C 1 -C 6烷基; 及其药学上可接受的盐。 本发明的化合物可用于作为主要镇静剂的治疗，例如在精神病性障碍的治疗中。